Tushar Pandey Awarded for His Enourmous Contribution to Hematology
Tushar Pandey, Editorial Board Member of Journal of Cancer Chemotherapy, shared on Facebook:
”I am honored to be awarded by the Honourable Chief Minister of Uttarakhand, Shri Pushkar Singh Dhami ji, in recognition of my work in Hematology and Hemato-Oncology across Kumaon, Uttarakhand, and the adjoining regions of Uttar Pradesh.
This recognition represents more than a personal milestone.
It reaffirms a deliberate choice I made early in my career—to build advanced, evidence-based hematology and cancer care in Haldwani, ensuring that patients from the hills and nearby regions have access to world-class treatment closer to home, rather than limiting practice to metro cities or opportunities abroad.
Over the years, the focus has remained constant: delivering ethical, guideline-driven, and outcome-oriented care for complex blood disorders and cancers, while strengthening regional capacity in Hematology, Hemato-Oncology, Bone Marrow Transplantation, and advanced cellular therapies.
I am deeply grateful to my patients and their families for their trust, and to my colleagues, nursing teams, technicians, hospital partners, and support staff for their unwavering commitment.
I also acknowledge my mentors and well-wishers, whose guidance has been invaluable.
Meaningful outcomes are always the result of strong teamwork.
This honor reinforces my responsibility to continue contributing to clinical excellence, innovation, and compassionate care for our region.
With gratitude and renewed commitment.”

More winner stories featured in Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis